Company Profiles

driven by the PitchBook Platform

Renopharm

2003 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$600k LATEST DEAL AMOUNT
$600k TOTAL AMOUNT RAISED
1 INVESTORS
Description

Developer of drug candidates for the treatment of hypertension and epilepsy. The company's drug candidates are based on novel no-donor compounds that do not evoke pro-drug tolerance.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
Industrial Zone
Nazareth 16000
Israel

+972 (0)4 656 4118
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Renopharm’s full profile, request a free trial.

Renopharm Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 16-Dec-2003 $600k $600k Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Renopharm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Next Generation Technology Venture Capital Minority 000 0000 000000 0

You’re viewing 1 of 1 investors.